Filing metadata

Accession number
0000899243-21-050130
Form type
Form 4
Filer
BridgeBio Pharma, Inc.
CIK
CIK 1743881
Filed
Dec 30, 2021
Reporting period
Dec 28, 2021
Description
Insider transaction

Explore SEC Filings Hub